SQUAWK/NEWS
Account
Theme
Account
Menu
Live News GEOPOLITICS FLASH H impact

IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2026: 83% Year-Over-Year Growth in U.S. Sales and Ma

CAESAREA, Israel, Nov. 18, 2026 // -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today reported its financial and opera…

ICCM

Related stories